| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-06-26 | 2009-04-30 | N-CSRS | Zimmer Holdings Inc | ZMH | US | Medical Products | 0 | Sold All | -111,945 | -100 % | - | - | - | 32.06 % | $-1,547,080 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Zimmer Holdings Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Xenoport Inc | XNPT | US | Medical-Drugs | 421,864 | Added More | 169,592 | 67.22 % | $8,838,051 | $6,897,476 | $-1,940,574 | -21.95 % | $-780,123 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Xenoport Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Wyeth | WYE | US | Medical-Drugs | 425,731 | Added More | 20,171 | 4.97 % | $19,170,667 | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Wyeth |
| 2009-06-26 | 2009-04-30 | N-CSRS | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 148,430 | New Holding | 148,430 | 100 % | $5,349,417 | $5,720,492 | $371,075 | 6.93 % | $371,075 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 563,220 | Sold Some | -203,855 | -26.57 % | $13,950,959 | $16,085,563 | $2,134,604 | 15.30 % | $-772,610 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Unitedhealth Group Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | United Therapeutics Corp | UTHR | US | Therapeutics | 144,611 | Added More | 10,939 | 8.18 % | $11,898,593 | $6,494,480 | $-5,404,113 | -45.41 % | $-408,790 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of United Therapeutics Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Theravance Inc | THRX | US | Therapeutics | 252,430 | Sold Some | -194,150 | -43.47 % | $3,647,614 | $3,544,117 | $-103,496 | -2.83 % | $79,602 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Theravance Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Stryker Corp | SYK | US | Medical Products | 209,250 | New Holding | 209,250 | 100 % | $8,547,863 | $10,196,753 | $1,648,890 | 19.29 % | $1,648,890 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Stryker Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Sequenom Inc | SQNM | US | Medical-Biomedical/Gene | 0 | Sold All | -619,305 | -100 % | - | - | - | -23.28 % | $588,340 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Sequenom Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Schering-Plough Corp | SGP | US | Medical-Drugs | 480,687 | Added More | 99,562 | 26.12 % | $11,805,673 | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Schering-Plough Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Savient Pharmaceuticals Inc | SVNT | US | Medical-Biomedical/Gene | 355,327 | Sold Some | -237,870 | -40.09 % | $5,113,156 | $4,907,066 | $-206,090 | -4.03 % | $137,965 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Savient Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | St Jude Medical Inc | STJ | US | Medical Instruments | 283,982 | Added More | 47,682 | 20.17 % | $11,833,530 | $9,746,262 | $-2,087,268 | -17.63 % | $-350,463 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of St Jude Medical Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Pharmstandard Ojsc | 70SK.L | US | Medical-Generic Drugs | 347,368 | Sold Some | -38,220 | -9.91 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Pharmstandard Ojsc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Pfizer Inc | PFE | US | Medical-Drugs | 520,590 | New Holding | 520,590 | 100 % | $7,907,762 | $9,558,032 | $1,650,270 | 20.86 % | $1,650,270 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Pfizer Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 338,015 | Added More | 12,660 | 3.89 % | $9,342,735 | $9,461,040 | $118,305 | 1.26 % | $4,431 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 258,187 | Added More | 34,047 | 15.19 % | $7,115,634 | $8,465,952 | $1,350,318 | 18.97 % | $178,066 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Osi Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 140,085 | Added More | 35,000 | 33.30 % | $4,846,941 | $3,306,006 | $-1,540,935 | -31.79 % | $-385,000 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Myriad Genetics Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Mylan Incpa | MYL | US | Medical-Generic Drugs | 442,008 | Sold Some | -231,537 | -34.37 % | $5,931,747 | $7,757,240 | $1,825,493 | 30.77 % | $-956,248 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Mylan Incpa |
| 2009-06-26 | 2009-04-30 | N-CSRS | Medtronic Inc | MDT | US | Medical Instruments | 178,304 | Sold Some | -55,771 | -23.82 % | $6,235,291 | $7,064,404 | $829,114 | 13.29 % | $-259,335 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Medtronic Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Medco Health Solutions Inc | MHS | US | Pharmacy Services | 245,475 | Sold Some | -6,443 | -2.55 % | $11,228,027 | $15,123,715 | $3,895,688 | 34.69 % | $-102,250 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Medco Health Solutions Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Martek Biosciences Corp | MATK | US | Medical-Biomedical/Gene | 195,148 | New Holding | 195,148 | 100 % | $4,236,663 | $3,534,130 | $-702,533 | -16.58 % | $-702,533 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Martek Biosciences Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Eli Lilly And Co | LLY | US | Medical-Drugs | 0 | Sold All | -114,740 | -100 % | - | - | - | 3.71 % | $-150,309 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Eli Lilly And Co |
| 2009-06-26 | 2009-04-30 | N-CSRS | Johnson And Johnson | JNJ | US | Medical Products | 159,752 | New Holding | 159,752 | 100 % | $9,041,963 | $9,954,147 | $912,184 | 10.08 % | $912,184 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Johnson And Johnson |
| 2009-06-26 | 2009-04-30 | N-CSRS | Intuitive Surgical Inc | ISRG | US | Medical Instruments | 57,193 | Sold Some | -12,472 | -17.90 % | $9,134,866 | $15,810,433 | $6,675,567 | 73.07 % | $-1,455,732 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Intuitive Surgical Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 0 | Sold All | -1,070,661 | -100 % | - | - | - | 115.09 % | $-4,325,470 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Incyte Corp Ltd |
| 2009-06-26 | 2009-04-30 | N-CSRS | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 1,046,496 | Sold Some | -28,416 | -2.64 % | $2,972,049 | $28,653,060 | $25,681,012 | 864.08 % | $-697,329 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Human Genome Sciences Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Humana Inc | HUM | US | Medical-Hmo | 199,019 | Sold Some | -112,491 | -36.11 % | $6,310,892 | $8,048,328 | $1,737,436 | 27.53 % | $-982,046 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Humana Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Hospira Inc | HSP | US | Drug Delivery Systems | 181,409 | Sold Some | -55,171 | -23.32 % | $7,025,971 | $8,504,454 | $1,478,483 | 21.04 % | $-449,644 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Hospira Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Hill-Rom Holdings Inc | HB | US | Hospital Beds/Equipment | 0 | Sold All | -205,791 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Hill-Rom Holdings Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Gilead Sciences Inc | GILD | US | Therapeutics | 423,093 | Sold Some | -3,789 | -0.88 % | $20,105,379 | $19,627,284 | $-478,095 | -2.37 % | $4,282 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Gilead Sciences Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 319,808 | Added More | 73,823 | 30.01 % | $18,069,152 | $16,006,390 | $-2,062,762 | -11.41 % | $-476,158 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Genzyme Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 0 | Sold All | -206,940 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Genentech Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Forest Laboratories Inc | FRX | US | Medical-Drugs | 377,901 | Added More | 2,921 | 0.77 % | $9,534,442 | $11,174,533 | $1,640,090 | 17.20 % | $12,677 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Forest Laboratories Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Thermo Fisher Scientific Inc | TMO | US | Instruments-Scientific | 168,723 | Added More | 77,443 | 84.84 % | $7,071,181 | $7,855,743 | $784,562 | 11.09 % | $360,110 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Thermo Fisher Scientific Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Exelixis Inc | EXEL | US | Medical-Biomedical/Gene | 0 | Sold All | -645,595 | -100 % | - | - | - | 32.87 % | $-1,071,688 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Exelixis Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Coventry Health Care Inc | CVH | US | Medical-Hmo | 0 | Sold All | -415,986 | -100 % | - | - | - | 18.44 % | $-1,460,111 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Coventry Health Care Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Cougar Biotechnology Inc | CGRB | US | Medical-Biomedical/Gene | 102,821 | Sold Some | -70,663 | -40.73 % | $4,421,303 | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Cougar Biotechnology Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 514,935 | Added More | 111,785 | 27.72 % | $24,732,328 | $28,275,081 | $3,542,753 | 14.32 % | $769,081 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Celgene Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Cvscaremark Corp | CVS | US | Retail-Drug Store | 602,820 | New Holding | 602,820 | 100 % | $18,904,435 | $19,073,225 | $168,790 | 0.89 % | $168,790 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Cvscaremark Corp |
| 2009-06-26 | 2009-04-30 | N-CSRS | Capitalsource Inc | CSE | US | Reits-Diversified | 0 | Sold All | -705,708 | -100 % | - | - | - | -20.92 % | $705,708 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Capitalsource Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 0 | Sold All | -161,280 | -100 % | - | - | - | 6.46 % | $-166,118 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Bayer Ag | BAYZF.OB | US | Chemicals-Diversified | 276,496 | Sold Some | -59,374 | -17.67 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Bayer Ag |
| 2009-06-26 | 2009-04-30 | N-CSRS | Baxter International Inc | BAX | US | Medical Products | 231,172 | Added More | 55,287 | 31.43 % | $12,078,737 | $12,559,575 | $480,838 | 3.98 % | $114,997 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Baxter International Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 217,974 | Added More | 26,856 | 14.05 % | $6,613,331 | $7,613,832 | $1,000,501 | 15.12 % | $123,269 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Array Biopharma Inc | ARRY | US | Medical-Drugs | 510,206 | Sold Some | -26,602 | -4.95 % | $1,729,598 | $1,035,718 | $-693,880 | -40.11 % | $36,179 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Array Biopharma Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Arena Pharmaceuticals Inc | ARNA | US | Medical-Biomedical/Gene | 588,494 | Sold Some | -267,459 | -31.24 % | $2,942,470 | $2,065,614 | $-876,856 | -29.80 % | $398,514 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Arena Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 193,278 | Sold Some | -3,762 | -1.90 % | $10,205,078 | $10,703,736 | $498,657 | 4.88 % | $-9,706 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Amgen Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 390,331 | Added More | 60,269 | 18.25 % | $15,211,199 | $17,057,465 | $1,846,266 | 12.13 % | $285,072 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Alexandria Real Estate Equities Inc | ARE | US | Reits-Office Property | 0 | Sold All | -57,925 | -100 % | - | - | - | 63.16 % | $-1,287,094 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Alexandria Real Estate Equities Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 455,145 | Sold Some | -34,399 | -7.02 % | $12,721,303 | $10,877,966 | $-1,843,337 | -14.49 % | $139,316 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Acorda Therapeutics Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Achillion Pharmaceuticals Inc | ACHN | US | Medical-Drugs | 874,717 | Sold Some | -23,763 | -2.64 % | $1,180,868 | $1,679,457 | $498,589 | 42.22 % | $-13,545 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Achillion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Abbott Laboratories | ABT | US | Medical-Drugs | 288,398 | Added More | 104,603 | 56.91 % | $13,678,717 | $15,469,669 | $1,790,952 | 13.09 % | $649,585 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Abbott Laboratories |
| 2009-06-26 | 2009-04-30 | N-CSRS | Tomotherapy Inc | TTPY | KY | Medical Products | 726,256 | Sold Some | -228,509 | -23.93 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Tomotherapy Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Glaxosmithkline Plc | GSK | IT | Medical-Drugs | 242,886 | New Holding | 242,886 | 100 % | $8,695,319 | $10,087,056 | $1,391,737 | 16.00 % | $1,391,737 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Glaxosmithkline Plc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Astrazeneca Plc | AZN | IT | Medical-Drugs | 380,896 | New Holding | 380,896 | 100 % | $17,067,950 | $17,071,759 | $3,809 | 0.02 % | $3,809 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Astrazeneca Plc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Reckitt Benckiser Group Plc | RBGPF.OB | GB | Soap And Cleaning Prepar | 120,665 | Sold Some | -400 | -0.33 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Reckitt Benckiser Group Plc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Sanofi-Aventis Sa | SNY | FR | Medical-Drugs | 0 | Sold All | -105,918 | -100 % | - | - | - | 34.48 % | $-1,023,168 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Sanofi-Aventis Sa |
| 2009-06-26 | 2009-04-30 | N-CSRS | Shire Plc | SHPGY | DE | Medical-Drugs | 173,561 | Sold Some | -4,740 | -2.65 % | $7,263,528 | $9,794,047 | $2,530,519 | 34.83 % | $-69,109 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Shire Plc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Alcon Inc | ACL | CH | Optical Supplies | 88,806 | Added More | 44,911 | 102.31 % | $10,340,571 | $12,899,960 | $2,559,389 | 24.75 % | $1,294,335 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Alcon Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Novartis Ag | NVS | CH | Medical-Drugs | 230,814 | Added More | 63,998 | 38.36 % | $9,541,851 | $12,263,148 | $2,721,297 | 28.51 % | $754,536 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Novartis Ag |
| 2009-06-26 | 2009-04-30 | N-CSRS | Roche Holding Ag | RHHBY.OB | CH | Medical-Drugs | 183,979 | Added More | 23,359 | 14.54 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Roche Holding Ag |
| 2009-06-26 | 2009-04-30 | N-CSRS | Odontoprev Sa | ODPV3.SA | BR | Medical-Hmo | 0 | Sold All | -603,750 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Odontoprev Sa |
| 2009-06-26 | 2009-04-30 | N-CSRS | Covidien Ltd | COV | BM | Medical Products | 332,744 | Added More | 7,194 | 2.20 % | $12,101,899 | $15,189,764 | $3,087,864 | 25.51 % | $66,760 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Covidien Ltd |
| 2009-06-26 | 2009-04-30 | N-CSRS | Bristol-Myers Squibb Co | BMY | BE | Medical-Drugs | 394,273 | Added More | 52,703 | 15.42 % | $8,263,962 | $9,643,918 | $1,379,956 | 16.69 % | $184,461 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Bristol-Myers Squibb Co |
| 2009-06-26 | 2009-04-30 | N-CSRS | Amag Pharmaceuticals Inc | AMAG | BE | Medical-Biomedical/Gene | 234,187 | Added More | 122,152 | 109.03 % | $12,795,978 | $9,308,933 | $-3,487,044 | -27.25 % | $-1,818,843 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Zimmer Holdings Inc | ZMH | US | Medical Products | 111,945 | Sold Some | -29,765 | -21.00 % | $4,085,993 | $6,371,909 | $2,285,917 | 55.94 % | $-607,801 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Zimmer Holdings Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Xenoport Inc | XNPT | US | Medical-Drugs | 252,272 | Added More | 84,695 | 50.54 % | $4,883,986 | $4,124,647 | $-759,339 | -15.54 % | $-254,932 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Xenoport Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Wyeth | WYE | US | Medical-Drugs | 405,560 | Sold Some | -120,900 | -22.96 % | $17,455,302 | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Wyeth |
| 2009-03-31 | 2009-01-31 | N-Q | Valeant Pharmaceuticals International | VRX | US | Medical-Drugs | 0 | Sold All | -89,600 | -100 % | - | - | - | 87.07 % | $-1,387,904 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Valeant Pharmaceuticals International |
| 2009-03-31 | 2009-01-31 | N-Q | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 767,075 | Added More | 28,680 | 3.88 % | $16,054,880 | $21,907,662 | $5,852,782 | 36.45 % | $218,828 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Unitedhealth Group Inc |
| 2009-03-31 | 2009-01-31 | N-Q | United Therapeutics Corp | UTHR | US | Therapeutics | 133,672 | Added More | 50,780 | 61.26 % | $8,834,382 | $6,003,210 | $-2,831,173 | -32.04 % | $-1,075,520 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of United Therapeutics Corp |
| 2009-03-31 | 2009-01-31 | N-Q | Theravance Inc | THRX | US | Therapeutics | 446,580 | Added More | 69,550 | 18.44 % | $7,591,860 | $6,269,983 | $-1,321,877 | -17.41 % | $-205,868 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Theravance Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Sequenom Inc | SQNM | US | Medical-Biomedical/Gene | 619,305 | Added More | 102,180 | 19.75 % | $8,806,517 | $1,938,425 | $-6,868,092 | -77.98 % | $-1,133,176 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Sequenom Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Schering-Plough Corp | SGP | US | Medical-Drugs | 381,125 | Sold Some | -135,570 | -26.23 % | $8,975,494 | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Schering-Plough Corp |
| 2009-03-31 | 2009-01-31 | N-Q | Savient Pharmaceuticals Inc | SVNT | US | Medical-Biomedical/Gene | 593,197 | Added More | 26,783 | 4.72 % | $2,936,325 | $8,192,051 | $5,255,725 | 178.98 % | $237,297 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Savient Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | St Jude Medical Inc | STJ | US | Medical Instruments | 236,300 | Added More | 23,935 | 11.27 % | $8,584,779 | $8,109,816 | $-474,963 | -5.53 % | $-48,109 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of St Jude Medical Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Pharmstandard Ojsc | 70SK.L | US | Medical-Generic Drugs | 385,588 | Added More | 150,166 | 63.78 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Pharmstandard Ojsc |
| 2009-03-31 | 2009-01-31 | N-Q | Pediatrix Medical Group Inc | PDX | US | Phys Practice Mgmnt | 0 | Sold All | -279,795 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Pediatrix Medical Group Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 325,355 | Sold Some | -62,225 | -16.05 % | $9,288,885 | $9,106,686 | $-182,199 | -1.96 % | $34,846 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Onyx Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 224,140 | Added More | 51,320 | 29.69 % | $8,575,596 | $7,349,551 | $-1,226,046 | -14.29 % | $-280,720 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Osi Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 105,085 | New Holding | 105,085 | 100 % | $4,778,215 | $2,480,006 | $-2,298,209 | -48.09 % | $-2,298,209 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Myriad Genetics Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Mylan Incpa | MYL | US | Medical-Generic Drugs | 673,545 | Added More | 218,805 | 48.11 % | $9,032,238 | $11,820,715 | $2,788,476 | 30.87 % | $905,853 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Mylan Incpa |
| 2009-03-31 | 2009-01-31 | N-Q | Merck And Co Incnj | MRK | US | Medical-Drugs | 0 | Sold All | -882,200 | -100 % | - | - | - | 36.29 % | $-8,566,162 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Merck And Co Incnj |
| 2009-03-31 | 2009-01-31 | N-Q | Medtronic Inc | MDT | US | Medical Instruments | 234,075 | Sold Some | -23,890 | -9.26 % | $6,898,190 | $9,274,052 | $2,375,861 | 34.44 % | $-242,484 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Medtronic Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Medco Health Solutions Inc | MHS | US | Pharmacy Services | 251,918 | Sold Some | -76,652 | -23.32 % | $10,414,290 | $15,520,668 | $5,106,378 | 49.03 % | $-1,553,736 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Medco Health Solutions Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Eli Lilly And Co | LLY | US | Medical-Drugs | 114,740 | Sold Some | -114,025 | -49.84 % | $3,833,463 | $4,198,337 | $364,873 | 9.51 % | $-362,600 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Eli Lilly And Co |
| 2009-03-31 | 2009-01-31 | N-Q | Intuitive Surgical Inc | ISRG | US | Medical Instruments | 69,665 | New Holding | 69,665 | 100 % | $6,643,254 | $19,258,193 | $12,614,938 | 189.89 % | $12,614,938 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Intuitive Surgical Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 1,070,661 | Added More | 787,346 | 277.90 % | $2,505,347 | $8,083,491 | $5,578,144 | 222.64 % | $4,102,073 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Incyte Corp Ltd |
| 2009-03-31 | 2009-01-31 | N-Q | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 1,074,912 | Sold Some | -107,865 | -9.11 % | $892,177 | $29,431,091 | $28,538,914 | 3198.79 % | $-2,863,816 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Human Genome Sciences Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Humana Inc | HUM | US | Medical-Hmo | 311,510 | Sold Some | -111,080 | -26.28 % | $8,124,181 | $12,597,464 | $4,473,284 | 55.06 % | $-1,595,109 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Humana Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Hospira Inc | HSP | US | Drug Delivery Systems | 236,580 | Added More | 46,575 | 24.51 % | $7,300,859 | $11,090,870 | $3,790,012 | 51.91 % | $746,132 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Hospira Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Hill-Rom Holdings Inc | HB | US | Hospital Beds/Equipment | 205,791 | New Holding | 205,791 | 100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Hill-Rom Holdings Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Gilead Sciences Inc | GILD | US | Therapeutics | 426,882 | Added More | 48,540 | 12.82 % | $19,773,174 | $19,803,056 | $29,882 | 0.15 % | $3,398 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Gilead Sciences Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 245,985 | Sold Some | -64,720 | -20.83 % | $14,609,049 | $12,311,549 | $-2,297,500 | -15.72 % | $604,485 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Genzyme Corp |
| 2009-03-31 | 2009-01-31 | N-Q | Genentech Inc | DNA | US | Medical-Biomedical/Gene | 206,940 | Added More | 515 | 0.24 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Genentech Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Forest Laboratories Inc | FRX | US | Medical-Drugs | 374,980 | Sold Some | -58,775 | -13.55 % | $8,234,561 | $11,088,159 | $2,853,598 | 34.65 % | $-447,278 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Forest Laboratories Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Thermo Fisher Scientific Inc | TMO | US | Instruments-Scientific | 91,280 | New Holding | 91,280 | 100 % | $3,255,958 | $4,249,997 | $994,039 | 30.52 % | $994,039 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Thermo Fisher Scientific Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Exelixis Inc | EXEL | US | Medical-Biomedical/Gene | 645,595 | Added More | 25,235 | 4.06 % | $2,969,737 | $4,331,942 | $1,362,205 | 45.86 % | $53,246 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Exelixis Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Coventry Health Care Inc | CVH | US | Medical-Hmo | 415,986 | Added More | 59,480 | 16.68 % | $5,382,859 | $9,376,324 | $3,993,466 | 74.18 % | $571,008 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Coventry Health Care Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Cougar Biotechnology Inc | CGRB | US | Medical-Biomedical/Gene | 173,484 | Added More | 21,835 | 14.39 % | $5,586,185 | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Cougar Biotechnology Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 403,150 | Sold Some | -3,245 | -0.79 % | $17,899,860 | $22,136,967 | $4,237,107 | 23.67 % | $-34,105 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Celgene Corp |
| 2009-03-31 | 2009-01-31 | N-Q | Capitalsource Inc | CSE | US | Reits-Diversified | 705,708 | Sold Some | -323,186 | -31.41 % | $860,964 | $2,667,576 | $1,806,612 | 209.83 % | $-827,356 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Capitalsource Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 0 | Sold All | -77,215 | -100 % | - | - | - | -11.52 % | $466,379 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Biogen Idec Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 161,280 | Sold Some | -219,450 | -57.63 % | $1,991,808 | $2,736,922 | $745,114 | 37.40 % | $-1,013,859 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Bayer Ag | BAYZF.OB | US | Chemicals-Diversified | 335,870 | Added More | 8,446 | 2.57 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Bayer Ag |
| 2009-03-31 | 2009-01-31 | N-Q | Baxter International Inc | BAX | US | Medical Products | 175,885 | New Holding | 175,885 | 100 % | $9,008,830 | $9,555,832 | $547,002 | 6.07 % | $547,002 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Baxter International Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Barr Pharmaceuticals Inc | BRL | US | Medical-Generic Drugs | 0 | Sold All | -116,545 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Barr Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 191,118 | Sold Some | -176,448 | -48.00 % | $5,297,791 | $6,675,752 | $1,377,961 | 26.01 % | $-1,272,190 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Array Biopharma Inc | ARRY | US | Medical-Drugs | 536,808 | Sold Some | -114,695 | -17.60 % | $1,417,173 | $1,089,720 | $-327,453 | -23.10 % | $69,964 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Array Biopharma Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Arena Pharmaceuticals Inc | ARNA | US | Medical-Biomedical/Gene | 855,953 | Added More | 140,190 | 19.58 % | $2,576,419 | $3,004,395 | $427,977 | 16.61 % | $70,095 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Arena Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 197,040 | Sold Some | -30,195 | -13.28 % | $9,757,421 | $10,912,075 | $1,154,654 | 11.83 % | $-176,943 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Amgen Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 330,062 | Added More | 131,461 | 66.19 % | $12,430,135 | $14,423,709 | $1,993,574 | 16.03 % | $794,024 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Alexandria Real Estate Equities Inc | ARE | US | Reits-Office Property | 57,925 | Sold Some | -23,280 | -28.66 % | $2,108,470 | $3,324,895 | $1,216,425 | 57.69 % | $-488,880 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Alexandria Real Estate Equities Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 489,544 | Sold Some | -17,602 | -3.47 % | $9,697,867 | $11,700,102 | $2,002,235 | 20.64 % | $-71,992 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Acorda Therapeutics Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Achillion Pharmaceuticals Inc | ACHN | US | Medical-Drugs | 898,480 | Added More | 78,100 | 9.51 % | $1,410,614 | $1,725,082 | $314,468 | 22.29 % | $27,335 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Achillion Pharmaceuticals Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Abbott Laboratories | ABT | US | Medical-Drugs | 183,795 | New Holding | 183,795 | 100 % | $8,767,022 | $9,858,764 | $1,091,742 | 12.45 % | $1,091,742 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Abbott Laboratories |
| 2009-03-31 | 2009-01-31 | N-Q | Tomotherapy Inc | TTPY | KY | Medical Products | 954,765 | Sold Some | -4,810 | -0.50 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Tomotherapy Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Elan Corp Plc | ELN | IE | Medical-Drugs | 0 | Sold All | -415,825 | -100 % | - | - | - | -2.71 % | $74,849 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Elan Corp Plc |
| 2009-03-31 | 2009-01-31 | N-Q | Reckitt Benckiser Group Plc | RBGPF.OB | GB | Soap And Cleaning Prepar | 121,065 | Sold Some | -34,678 | -22.26 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Reckitt Benckiser Group Plc |
| 2009-03-31 | 2009-01-31 | N-Q | Sanofi-Aventis Sa | SNY | FR | Medical-Drugs | 105,918 | Sold Some | -547 | -0.51 % | $2,958,290 | $3,989,931 | $1,031,641 | 34.87 % | $-5,328 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Sanofi-Aventis Sa |
| 2009-03-31 | 2009-01-31 | N-Q | Shire Plc | SHPGY | DE | Medical-Drugs | 178,301 | Sold Some | -74,685 | -29.52 % | $6,408,138 | $10,061,525 | $3,653,387 | 57.01 % | $-1,530,296 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Shire Plc |
| 2009-03-31 | 2009-01-31 | N-Q | Ks Ag | KUNAF.OB | DE | Chemicals-Diversified | 0 | Sold All | -156,782 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Ks Ag |
| 2009-03-31 | 2009-01-31 | N-Q | Merck Kgaa | MKGAF.PK | DE | Medical-Drugs | 0 | Sold All | -117,036 | -100 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Merck Kgaa |
| 2009-03-31 | 2009-01-31 | N-Q | Alcon Inc | ACL | CH | Optical Supplies | 43,895 | Sold Some | -19,010 | -30.22 % | $3,990,494 | $6,376,188 | $2,385,693 | 59.78 % | $-1,033,194 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Alcon Inc |
| 2009-03-31 | 2009-01-31 | N-Q | Novartis Ag | NVS | CH | Medical-Drugs | 166,816 | Sold Some | -127,764 | -43.37 % | $6,310,649 | $8,862,934 | $2,552,285 | 40.44 % | $-1,954,789 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Novartis Ag |
| 2009-03-31 | 2009-01-31 | N-Q | Syngenta Ag | SYT | CH | Agricultural Chemicals | 0 | Sold All | -36,863 | -100 % | - | - | - | 31.03 % | $-458,944 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Syngenta Ag |
| 2009-03-31 | 2009-01-31 | N-Q | Roche Holding Ag | RHHBY.OB | CH | Medical-Drugs | 160,620 | Sold Some | -22,406 | -12.24 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Roche Holding Ag |
| 2009-03-31 | 2009-01-31 | N-Q | Odontoprev Sa | ODPV3.SA | BR | Medical-Hmo | 603,750 | Added More | 147,930 | 32.45 % | - | - | - | - % | | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Odontoprev Sa |
| 2009-03-31 | 2009-01-31 | N-Q | Covidien Ltd | COV | BM | Medical Products | 325,550 | Sold Some | -1,040 | -0.31 % | $10,821,282 | $14,861,358 | $4,040,076 | 37.33 % | $-12,906 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Covidien Ltd |
| 2009-03-31 | 2009-01-31 | N-Q | Bristol-Myers Squibb Co | BMY | BE | Medical-Drugs | 341,570 | New Holding | 341,570 | 100 % | $7,487,214 | $8,354,802 | $867,588 | 11.58 % | $867,588 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Bristol-Myers Squibb Co |
| 2009-03-31 | 2009-01-31 | N-Q | Amag Pharmaceuticals Inc | AMAG | BE | Medical-Biomedical/Gene | 112,035 | New Holding | 112,035 | 100 % | $4,119,527 | $4,453,391 | $333,864 | 8.10 % | $333,864 | | | | | | News Article | History of Janus Investment Fund - Janus Global Life Sciences Fund Ownership Of Amag Pharmaceuticals Inc |